Rheumatology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?


Article ID

Home
General Rheumatology
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Rheumatology
        Amyloidosis
        Autoimmune/Heritable
        Basic Science/Genetics
        Bone Metabolism
        Chr Fatigue/Fibromyalgia
        Clinical Pharmacology
        Connective Tissue Dz
        Diagnostics/Radiology
        Economics of Medicine
        Gout and Hyperuricemia
        Infectious Arthritis
        Osteoarthritis
        Other Arthritis
        Pediatric Rheumatology
        Popular Press
        Rheumatoid Arthritis
        Spondylarthropathies
        Systemic Lupus (SLE)
        Vasculitic Syndromes
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
Top Ten Searches
rheumatoid arthritis  rheumatoid arthritis
lupus  lupus
polymyalgia  polymyalgia
sjogrens  sjogrens
fibromyalgia  fibromyalgia
amyloidosis  amyloidosis
vasculitis  vasculitis
urate  urate
raynauds  raynauds
myositis  myositis
 
Sponsor
MDLinx Email Article

To email this article, enter your own "From Email" address,
the recipient's "To Email" address, and click the "Send Email" button.
You may send to up to 5 email addresses.
*From Email:  
*To Email:  
To Email:  
To Email:  
To Email:  
To Email:  
Is pregabalin a safe and effective treatment for patients with fibromyalgia?
Spaeth M - Pregabalin is safe and effective for the treatment of fibromyalgia, but further studies are needed to determine whether other treatments should be considered instead of, or in addition to, pregabalin, in pts who do not show a sufficient response.

Methods
  • 748 pts with fibromyalgia to receive placebo (n=190) or pregabalin to assess the safety and efficacy of drug
  • Doses - 300 mg/d, 450 mg/d, or 600 mg/d twice daily for 13 wks
  • Pregabalin was initially administered at 150 mg/d then escalated to the fixed dose within 1 wk
  • Safety and efficacy of pregabalin dosages for the relief of fibromyalgia pain was assessed

Results
  • Relief from symptomatic pain was achieved in pts treated with pregabalin 300 mg, 450 mg, and 600 mg/d vs placebo
  • Patient Global Impression of Change and sleep scale scores were improved in all treatment groups at the 13-wk end point
  • Dizziness and somnolence - the two most common dose-related AEs
  • The results support the use of pregabalin in treatment for pain and sleep disturbances in fibromyalgia pts
[more...]
Sponsor

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Profession Index

Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.